Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

TORONTO and EDMONTON, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) ("Aeterna") and Ceapro Inc. (TSXV:CZO, OTCQX:CRPOF) ("Ceapro") are pleased to announce that securityholders of both biopharmaceutical development companies approved the all-stock merger of equals transaction (the "Transaction") at their respective special meetings held today. The specific voting results were as follows: Aeterna shareholders approved the Transaction with the following voting results: Resol ...